Schedule 13G ownership disclosure

NEWAMSTERDAM PHARMA COMPANY

Security class unavailable · CUSIP: N62509109

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.2900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-124124
Form type
SC 13G
Filer
NewAmsterdam Pharma Co N.V.
CIK
CIK 1936258
Filed
Dec 02, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub